- Home
- FENC vs LTRX Comparison
FENC vs LTRX Comparison
Compare FENC & LTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FENC | LTRX |
|---|---|---|
| Founded | 1996 | 1989 |
| Country | United States | United States |
| Employees | 35 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Communications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 350.0M | 328.9M |
| IPO Year | 2010 | 2000 |
Fundamental Metrics
Financial Performance| Metric | FENC | LTRX |
|---|---|---|
| Price | $9.98 | $5.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 6 |
| Target Price | ★ $17.67 | $10.58 |
| AVG Volume (30 Days) | 115.9K | ★ 1.0M |
| Earning Date | 11-12-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 65.52 |
| EPS | ★ 0.06 | N/A |
| Revenue | $44,642,000.00 | ★ $120,899,000.00 |
| Revenue This Year | $62.55 | $14.67 |
| Revenue Next Year | $42.10 | $13.36 |
| P/E Ratio | $172.50 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.65 | $4.37 |
| 52 Week High | $13.25 | $8.75 |
Technical Indicators
Market Signals| Indicator | FENC | LTRX |
|---|---|---|
| Relative Strength Index (RSI) | 40.60 | 35.58 |
| Support Level | $9.87 | $5.60 |
| Resistance Level | $10.66 | $6.09 |
| Average True Range (ATR) | 0.49 | 0.29 |
| MACD | -0.02 | -0.19 |
| Stochastic Oscillator | 12.90 | 8.47 |
Price Performance
Historical ComparisonAbout FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About LTRX Lantronix Inc.
Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The company operates in a single operating segment: the development, marketing, and sale of industrial and enterprise IoT products and services. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic regions: the Americas; EMEA; and APJ. The Americas contribute the vast majority of total revenue.